Press "Enter" to skip to content

Column: Drug makers see disaster in Medicare negotiating prices. Don't listen to them

A Democratic bill that would allow Medicare to negotiate drug prices has drawn stark — and overblown — warnings from the U.S. pharmaceutical industry.

Source: Los Angeles Times

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: